Potential molecular mechanism of radiation-induced cytotoxicity of Cetrimonium bromide to head and neck cancer cells

Authors

  • Jian Zhang Dr. J Consulting, Atlanta, GA, USA.

DOI:

https://doi.org/10.30574/gscbps.2021.16.3.0291

Keywords:

Cetrimonium bromide, Radiation, Tyrosine, Photochemical reaction, Slow tumor growth

Abstract

A previous study has shown that Cetrimonium bromide has a slight cytotoxicity to head and neck cancer cells due to the presence of the cationic quaternary amine group in this molecule that affects the function of mitochondria.The same study also found that the cytotoxicity of Cetrimonium bromide increased when combined with gamma radiation and this could be used to treat head and neck cancer in a mice in vivo tumor model.In the current study, an in vitro photochemical reaction between Cetrimonium chloride and tyrosine was investigated in order to understand the molecular mechanism of the in vivo observations and data. I found that Cetrimonium chloride could react with tyrosine upon simulated solar irradiation to produce an imine Schiff base which turned into cyano-tyrosine and a melanin polymer.It is possible that in the in vivo study mentioned earlier, the gamma radiation and Cetrimonium bromide together destroyed the tyrosine residues in some cellular proteins chemically, and as a result, tyrosine phosphorylation was inhibited in the cancer cells which slowed the growth of the tumor.

Metrics

Metrics Loading ...

References

Liu FF, Ito E, Inks K. Sensitizing agents for cancer therapy, methods of use and methods for identification thereof. US patent No. US 8,637,481 B2. 2014 Jan. 28.

Kua VF, Ismail F, Phua VCE, Aslan NM. Carboplatin/5-fluorouracil as an Alternative to Cisplatin/5- Fluorouracil for Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma. Asian Pacific Journal of Cancer Prevention. 2013; 14(2): 1121-1126.

Chen XC, Hong Y, Feng J, Ye J. Concurrent chemoradiotherapy comparison of taxanes and platinum versus 5-fluorouracil and platinum in nasopharyngeal carcinoma treatment. Chinese Medical Journal. 2014; 127(1):142-9.

Ito E, Yip KW, Katz D, Fonseca SB, Hedley DW, Chow S, Xu GW, Wood TE, Bastianutto C, Schimmer AD, Kelley SO, Liu FF. Potential Use of Cetrimonium Bromide as an Apoptosis- Promoting Anticancer Agent for Head and Neck Cancer. MolPharmacol. 2009; 76: 969–983.

Zhang J,Kalonia DS. The effect of neighboring amino acid residues and solution environments on the oxidative stability of tyrosine in small peptides. AAPS PharmSciTech. 2007; 8(4):176-183.

Zhang J. Photo-reaction of tyrosine with cetyltrimethylamonium chloride and nitrogen containing functional groups. US Patent Application Publication No. 2011/0046414 A1. 2011.

Eckhart W, Hutchinson MA, Hunter T. An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell. 1979; 18:925-933.

Downloads

Published

2021-09-30

How to Cite

Zhang, J. . (2021). Potential molecular mechanism of radiation-induced cytotoxicity of Cetrimonium bromide to head and neck cancer cells. GSC Biological and Pharmaceutical Sciences, 16(3), 241–244. https://doi.org/10.30574/gscbps.2021.16.3.0291